Sequential Immune Modulation and Antigen-Specific Tolerance Induction for Disease Modification in Recent-Onset Type 1 Diabetes

Clinical trial NCT07610213 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07610213
Sponsor: Abdullah Kars
Status: NOT_YET_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Type 1 Diabetes Mellitus (T1DM)Type 1 Diabetes Mellitus Autoimmune Diabetes

Start date: 2027-01-01
Primary completion: 2029-12-31
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.